Proloterapia para la tendinopatía de Aquiles

Hau Pham1, Wei Tseng1, Ewald R Mendeszoon1

  • 1*Department of Surgery, Boston Medical Center, Boston, MA. Dr. Wong is now part of a practice group in Oceanside, CA. Dr. Hutchins is now at Whittier Street Health Center, Boston, MA, and Providence Community Health Centers, Providence, RI. Dr. Amin is now in private practice in Jacksonville, FL. Dr. Reubens is now part of a practice group in Harrisburg, PA.

Resumen

La proloterapia trató eficazmente la tendinitis de Aquiles en el 74,2 % de los pacientes en 12 meses. Esta técnica de inyección regenerativa muestra resultados prometedores para el alivio del dolor del tendón de Aquiles.

Videos de Conceptos Relacionados

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...